Samson Symchowicz

1.5k total citations
58 papers, 1.2k citations indexed

About

Samson Symchowicz is a scholar working on Pharmacology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Samson Symchowicz has authored 58 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 13 papers in Molecular Biology and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Samson Symchowicz's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Neuroscience and Neuropharmacology Research (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Samson Symchowicz is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Neuroscience and Neuropharmacology Research (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Samson Symchowicz collaborates with scholars based in United States, United Kingdom and China. Samson Symchowicz's co-authors include Elaine Radwanski, Nicola Zampaglione, James Hilbert, George Perentesis, C.A. Korduba, Richard Gural, Melton B. Affrime, J. Veals, Edwin A. Peets and Menger Chung and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Allergy and Clinical Immunology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Samson Symchowicz

58 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samson Symchowicz United States 22 268 204 194 124 122 58 1.2k
M Hichens United States 27 631 2.4× 184 0.9× 87 0.4× 155 1.3× 107 0.9× 52 1.9k
Gaston Labrecque Canada 20 152 0.6× 233 1.1× 281 1.4× 123 1.0× 115 0.9× 60 1.1k
A. Darragh Ireland 19 182 0.7× 199 1.0× 71 0.4× 127 1.0× 80 0.7× 71 1.1k
Ross Dixon United States 21 390 1.5× 93 0.5× 58 0.3× 174 1.4× 126 1.0× 50 1.3k
M.Maureen Dale United Kingdom 15 395 1.5× 150 0.7× 341 1.8× 99 0.8× 65 0.5× 47 1.4k
J. Rosenthaler Japan 16 198 0.7× 80 0.4× 60 0.3× 106 0.9× 87 0.7× 32 788
R. R. Brown United States 32 970 3.6× 143 0.7× 411 2.1× 132 1.1× 266 2.2× 100 3.3k
Shang‐Ying P. King United States 13 221 0.8× 121 0.6× 180 0.9× 89 0.7× 66 0.5× 21 928
Nobuhiro Inatomi Japan 27 592 2.2× 200 1.0× 249 1.3× 208 1.7× 149 1.2× 73 2.5k
Charles A. Winter United States 18 400 1.5× 344 1.7× 204 1.1× 232 1.9× 238 2.0× 32 1.5k

Countries citing papers authored by Samson Symchowicz

Since Specialization
Citations

This map shows the geographic impact of Samson Symchowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samson Symchowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samson Symchowicz more than expected).

Fields of papers citing papers by Samson Symchowicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samson Symchowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samson Symchowicz. The network helps show where Samson Symchowicz may publish in the future.

Co-authorship network of co-authors of Samson Symchowicz

This figure shows the co-authorship network connecting the top 25 collaborators of Samson Symchowicz. A scholar is included among the top collaborators of Samson Symchowicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samson Symchowicz. Samson Symchowicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barr, William H., Chin‐Chung Lin, Elaine Radwanski, et al.. (1991). The pharmacokinetics of ceftibuten in humans. Diagnostic Microbiology and Infectious Disease. 14(1). 93–100. 44 indexed citations
2.
Newth, Christopher J. L., Martine B. Powell, Peter C. K. Leung, et al.. (1989). Influence of food on the absorption of albuterol Repetabs. Journal of Allergy and Clinical Immunology. 83(1). 123–126. 10 indexed citations
3.
Radwanski, Elaine, et al.. (1988). Secretion of Dilevalol in Breast Milk. The Journal of Clinical Pharmacology. 28(5). 448–453. 7 indexed citations
4.
Hilbert, James, A G Parks, Elaine Radwanski, et al.. (1988). The Pharmacokinetics of Loratadine in Normal Geriatric Volunteers. Journal of International Medical Research. 16(1). 50–60. 24 indexed citations
5.
Hilbert, James, Elaine Radwanski, Melton B. Affrime, et al.. (1988). Excretion of Loratadine in Human Breast Milk. The Journal of Clinical Pharmacology. 28(3). 234–239. 57 indexed citations
6.
Kramer, William G., et al.. (1988). Pharmacokinetics and Bioavailability of Dilevalol in Normotensive Volunteers. The Journal of Clinical Pharmacology. 28(7). 644–648. 12 indexed citations
7.
Radwanski, Elaine, George Perentesis, Sheila Jacobs, et al.. (1987). Pharmacokinetics of Interferon α‐2b in Healthy Volunteers. The Journal of Clinical Pharmacology. 27(5). 432–435. 65 indexed citations
8.
Powell, Mark L., et al.. (1987). Comparative steady state bioavailability of conventional and controlled‐release formulations of albuterol. Biopharmaceutics & Drug Disposition. 8(5). 461–468. 14 indexed citations
9.
Radwanski, Elaine, James Hilbert, Samson Symchowicz, & Nicola Zampaglione. (1987). Loratadine: Multiple‐Dose Pharmacokinetics. The Journal of Clinical Pharmacology. 27(7). 530–533. 44 indexed citations
10.
Hilbert, James, et al.. (1987). Pharmacokinetics and Dose Proportionality of Loratadine. The Journal of Clinical Pharmacology. 27(9). 694–698. 101 indexed citations
11.
Zampaglione, Nicola, et al.. (1985). Disposition and metabolic fate of 14C-quazepam in man.. Drug Metabolism and Disposition. 13(1). 25–29. 27 indexed citations
12.
Hilbert, James, B C Pramanik, Samson Symchowicz, & Nicola Zampaglione. (1984). The disposition and metabolism of a hypnotic benzodiazepine, quazepam, in the hamster and mouse.. Drug Metabolism and Disposition. 12(4). 452–459. 4 indexed citations
13.
Chung, Menger, James Hilbert, Richard Gural, et al.. (1984). Multiple-dose quazepam kinetics. Clinical Pharmacology & Therapeutics. 35(4). 520–524. 17 indexed citations
14.
Hilbert, James, et al.. (1984). Effect of sleep on quazepam kinetics. Clinical Pharmacology & Therapeutics. 36(1). 99–104. 20 indexed citations
15.
Hilbert, James, Richard Gural, Samson Symchowicz, & Nicola Zampaglione. (1984). Excretion of Quazepam Into Human Breast Milk. The Journal of Clinical Pharmacology. 24(10). 457–462. 21 indexed citations
16.
Korduba, C.A., J. Veals, A. Wöhl, Samson Symchowicz, & I.I.A. Tabachnick. (1973). SCH 10595, AN EFFECTIVE DOPAMINE-β-HYDROXYLASE INHIBITOR AND A HYPOTENSIVE AGENT. Journal of Pharmacology and Experimental Therapeutics. 184(3). 671–677. 3 indexed citations
17.
Symchowicz, Samson, et al.. (1970). A Biomedical Model for Absorption Studies from Various Gastrointestinal Sites in Dogs. American Journal of Veterinary Research. 31(7). 1293–1296. 1 indexed citations
18.
Peets, Edwin A., et al.. (1969). Plasma binding of betamethasone3H, dexamethasone-3H, and cortisol-14C— A comparative study. Biochemical Pharmacology. 18(7). 1655–1663. 67 indexed citations
19.
Wong, Keith, et al.. (1967). The effect of cathecholamines, diazoxide and theophylline on insulin release. Life Sciences. 6(21). 2285–2291. 20 indexed citations
20.
Symchowicz, Samson, et al.. (1966). Metabolism of griseofulvin-14C; Studies in vitro. Biochemical Pharmacology. 15(10). 1601–1606. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Hichens Breakdown of academic impact, for papers by Gaston Labrecque Breakdown of academic impact, for papers by A. Darragh Breakdown of academic impact, for papers by Ross Dixon Breakdown of academic impact, for papers by M.Maureen Dale Breakdown of academic impact, for papers by J. Rosenthaler Breakdown of academic impact, for papers by R. R. Brown Breakdown of academic impact, for papers by Shang‐Ying P. King Breakdown of academic impact, for papers by Nobuhiro Inatomi Breakdown of academic impact, for papers by Charles A. Winter
Rankless by CCL
2026